Table 3 The expression of NF-κB mRNA in the tumorous and non-tumorous tissue sections of CRC versus adenoma patients and in CRC-Sg+ve versus CRC-Sg-ve groups.
tissue sections | Positive NF-κB mRNA expression N (%) | χ2 test Pvalue | Mean % of NFKB-positively stained cells | P value for positively stained cells |
|---|---|---|---|---|
Tumorous tissue sections | ||||
Patients: | Â | Â | Â | Â |
CRC | 36/50 (72) | 0.042 | 74.7 ± 4.7 | <0.01 |
Adenoma | 7/14 (50) |  | 57.73 ± 5.6 |  |
S. gallolyticus seropositivity | Â | Â | Â | Â |
CRC-Sg+ve | 28/34 (82) | 0.017 | 79.45 ± 6.2 | <0.05 |
CRC-Sg-ve | 8/16 (50) |  | 64.6 ± 4.6 |  |
Non-tumorous tissue sections | ||||
Patients: | Â | Â | Â | Â |
CRC | 19/50 (38) | 0.09 | 36.23 ± 3.6 | >0.05 |
Adenoma | 2/14 (14.2) |  | 27.85 ± 5.8 |  |
S. gallolyticus seropositivity | Â | Â | Â | Â |
CRC-Sg+ve | 17/34 (50) | 0.01 | 40.25 ± 3.7 | <0.05 |
CRC-Sg-ve | 2/16 (12.5) |  | 27.7 ± 4.2 |  |